ACM
AlphaCrest Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,944
| Closed | -$3.55M | – | 387 |
|
|
2022
Q3 | $3.55M | Buy |
42,944
+39,367
| +1,101% | +$3.25M | 0.22% | 67 |
|
|
2022
Q2 | $340K | Sell |
3,577
-2,341
| -40% | -$223K | 0.02% | 1077 |
|
|
2022
Q1 | $697K | Sell |
5,918
-932
| -14% | -$110K | 0.04% | 732 |
|
|
2021
Q4 | $887K | Sell |
6,850
-14,861
| -68% | -$1.92M | 0.03% | 848 |
|
|
2021
Q3 | $2.46M | Buy |
21,711
+12,415
| +134% | +$1.41M | 0.13% | 209 |
|
|
2021
Q2 | $963K | Sell |
9,296
-42,148
| -82% | -$4.37M | 0.04% | 679 |
|
|
2021
Q1 | $4.3M | Buy |
51,444
+34,031
| +195% | +$2.85M | 0.24% | 85 |
|
|
2020
Q4 | $1.59M | Buy |
17,413
+3,015
| +21% | +$275K | 0.13% | 189 |
|
|
2020
Q3 | $1.15M | Sell |
14,398
-25,195
| -64% | -$2.01M | 0.12% | 210 |
|
|
2020
Q2 | $2.74M | Buy |
39,593
+30,707
| +346% | +$2.12M | 0.46% | 21 |
|
|
2020
Q1 | $1.68M | Buy |
8,886
+179
| +2% | +$33.8K | 0.2% | 116 |
|
|
2019
Q4 | $2.03M | Buy |
8,707
+4,507
| +107% | +$1.05M | 0.17% | 110 |
|
|
2019
Q3 | $924K | Sell |
4,200
-7,586
| -64% | -$1.67M | 0.06% | 615 |
|
|
2019
Q2 | $2.18M | Buy |
11,786
+9,785
| +489% | +$1.81M | 0.19% | 132 |
|
|
2019
Q1 | $383K | Sell |
2,001
-2,099
| -51% | -$402K | 0.06% | 570 |
|
|
2018
Q4 | $628K | Buy |
+4,100
| New | +$628K | 0.19% | 168 |
|